Financial statement analysis is sometimes incorrectly viewed as only the computation of a set of financial ratios, i.e. divide financial statement numbers by other numbers within the financial statement. This approach often fails to lead to concrete conclusions. Two computational methods are best employed: Ratio analysis coupled with common size financial statements should be the first steps in any comprehensive financial statement analysis. They are relatively easy to prepare, as long as you have the data, and they are easy to use.
This exhaustive financial analysis report contains:
GREAT FEATURE: To find the meaning or usage of any term, just click on the term to enter the Glossary.
CREATE YOUR OWN SAMPLE: Enter stock ticker below and click 'Submit'
Zhong Yuan Bio-Technology Hold, , SIC Code: 2836, BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
View Common Size Report for Zhong Yuan Bio-Technology Hold View Financial Statements Report for Zhong Yuan Bio-Technology Hold
TERM | Qtr. End 09/30/2023 | Qtr. End 06/30/2022 | Year End 03/31/2023 | Year End 03/31/2022 | Year End 03/31/2021 | Year End 03/31/2020 | Year End 03/31/2019 |
---|---|---|---|---|---|---|---|
Net Sales in $M | 0.5 | 0.3 | 1.7 | 2.3 | 1.6 | 1.2 | 1.2 |